Nicola F G, McDougal L K, Biddle J W, Tenover F C
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Antimicrob Agents Chemother. 1998 Nov;42(11):3024-7. doi: 10.1128/AAC.42.11.3024.
We tested 16 erythromycin-resistant clinical isolates of S. aureus, recovered from patients hospitalized in the United States from 1958 to 1969, for the presence of ermA, ermB, and ermC by using PCR. Fifteen of 16 isolates contained at least one copy of ermA; the remaining isolate, which was also clindamycin resistant, contained ermB. Eight of the 15 isolates harboring ermA, all of which were inducible, contained a single copy of the gene in the chromosome, while the remaining seven isolates had two copies of the gene. ermB was plasmid encoded and mediated constitutive resistance to erythromycin.
我们运用聚合酶链反应(PCR),检测了1958年至1969年期间从美国住院患者身上分离出的16株耐红霉素金黄色葡萄球菌临床分离株,以确定是否存在ermA、ermB和ermC。16株分离株中有15株至少含有一个ermA拷贝;其余一株同时对克林霉素耐药,含有ermB。携带ermA的15株分离株中有8株,均为诱导型,在染色体上含有该基因的一个拷贝,而其余7株分离株有两个该基因的拷贝。ermB由质粒编码,并介导对红霉素的组成型耐药。